Document is current
Any future updates will be listed below
-
Authors
Papier, Keren https://orcid.org/0000-0002-4102-6835
Bradbury, Kathryn E. https://orcid.org/0000-0003-3345-7333
Balkwill, Angela
Barnes, Isobel
Smith-Byrne, Karl https://orcid.org/0000-0002-1932-7463
Gunter, Marc J.
Berndt, Sonja I.
Le Marchand, Loic
Wu, Anna H.
Peters, Ulrike https://orcid.org/0000-0001-5666-9318
Beral, Valerie
Key, Timothy J. https://orcid.org/0000-0003-2294-307X
Reeves, Gillian K.
-
Funding
Funding for this research was provided by:
Cancer Research UK (C570/A16491 and A29186)
- License Information
-
More Information
Article History
Received: 3 July 2024
Accepted: 3 December 2024
First Online: 8 January 2025
Competing interests
: UP was a consultant with AbbVie and her husband is holding individual stocks for the following companies: BioNTech SE – ADR, Amazon, CureVac BV, NanoString Technologies, Google/Alphabet Inc Class C, NVIDIA Corp, Microsoft Corp. The remaining authors declare no competing interests.
